A Silsarma
YOU?
Author Swipe
View article: Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study
Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study Open
Background Bedaquiline (BDQ) resistance presents a critical challenge in the fight against tuberculosis (TB), particularly multidrug-resistant (MDR) strains. The emergence of resistance to BDQ, a key drug in treating MDR-TB, poses signific…
View article: Sustained treatment success at 12 months for drug-resistant TB patients on concomitant bedaquiline-delamanid
Sustained treatment success at 12 months for drug-resistant TB patients on concomitant bedaquiline-delamanid Open
View article: Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study
Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study Open
Treating INH mono-resistant patients with LfxREZ resulted in satisfactory outcomes and low toxicity. It is important to rule out drug resistance to INH while determining the treatment regimen.
View article: Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India
Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India Open
View article: Concomitant Bedaquiline and Delamanid Therapy in Patients with Drug-Resistant Extra-Pulmonary Tuberculosis in Mumbai, India
Concomitant Bedaquiline and Delamanid Therapy in Patients with Drug-Resistant Extra-Pulmonary Tuberculosis in Mumbai, India Open
View article: Linezolid resistance in patients with drug-resistant TB
Linezolid resistance in patients with drug-resistant TB Open